Method for the preparation of cells of mesodermal lineage
First Claim
1. A method for directing a population of cells to differentiate along a mesodermal cell lineage, said method comprising culturing said cells in the presence of bone morphogenetic protein 4 (BMP4) or a homologue, analogue or functional equivalent thereof for a time and under conditions sufficient for said cells to preferentially differentiate into mesodermal cells or cells of a mesodermal lineage.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates generally to the generation of cells of mesodermal lineage. More particularly, the present invention contemplates a method for the preparation of differentiated or partially differentiated mesodermal cells and their use in tissue repair, regeneration and/or augmentation therapy. The identification and generation of the mesodermal cells further provides a source of transcriptome or proteome data to assess the expression profile of genes associated with the maintenance of mesodermal cells as well as their differentiation, proliferation, expansion and/or renewal potential.
53 Citations
35 Claims
- 1. A method for directing a population of cells to differentiate along a mesodermal cell lineage, said method comprising culturing said cells in the presence of bone morphogenetic protein 4 (BMP4) or a homologue, analogue or functional equivalent thereof for a time and under conditions sufficient for said cells to preferentially differentiate into mesodermal cells or cells of a mesodermal lineage.
-
10. A method for generating mesodermal cells from ES or EPL cells said method comprising:
-
(a) culturing ES cells or EPL cells in MEDII or its functional equivalent in order to generate embryoid bodies (EBM);
(b) maintaining said EBMs in culture for a time sufficient to allow aggregation of said EBMs;
(c) transferring said aggregated EBMs to gelatin-treated wells;
(d) allowing said aggregated EBMs to adhere to said gelatin-treated wells; and
(e) culturing said adhered EBMs in serum free medium comprising BMP4 for a time sufficient to allow said EBMs to generate mesodermal cells, and thereby generating mesodermal cells from ES cells or EPL cells. - View Dependent Claims (11, 12, 13, 14, 15)
-
-
16. Mesodermal cells prepared by the process of culturing stem cells, or EPL cells or their committed progenitor cells in the presence of BMP4 for a time and under conditions sufficient for mesodermal cells to appear.
-
17. A method for screening for a change in a developmental stage of an EPL or other stem cell or mesodermal cell, said method comprising:
exposing an in vitro or ex vivo culture or suspension of EPL or other stem cell or mesodermal cells to an agent having a potential to induce proliferation and/or differentiation and/or self-renewal, wherein the level of proliferation and/or differentiation and/or self-renewal is determinable by a surface marker on said cells, contacting said cell surface with a ligand for said surface marker, and detecting the presence of binding to said surface marker, wherein the pattern of surface markers determines whether an agent has induced proliferation and/or differentiation of said EPL or other stem cell. - View Dependent Claims (18, 19, 20)
-
21. A method for determining a developmental stage of an EPL or other stem cell or mesodermal cell or cell developmentally in-between after exposure to a potential proliferating- or differentiating- or self-renewal-stimulating agent, said method comprising:
-
capturing said EPL or other stem cell or mesodermal cell or cell developmentally in-between by immobilization to an anchored antibody to a solid support, and screening said immobilized cell with a range of antibodies labeled with separate reporter molecules or a range of anti-immunoglobulin antibodies each labeled with a reporter molecule used to determine existence of particular antigens said antigens being indicative of the developmental stage of the cell. - View Dependent Claims (22, 23, 24)
-
-
25. A method for tissue repair, regeneration and/or augmentation, said method comprising:
-
generating mesodermal cells by culturing EPL cells or stem cells in the presence of an effective amount of BMP4 or a functional equivalent thereof for a time and under conditions sufficient to generate mesodermal cells, and introducing the mesodermal cells into a subject requiring tissue repair, regeneration and/or augmentation. - View Dependent Claims (26, 27, 28, 29, 30, 31, 32, 33, 34)
-
-
35. A composition comprising a modulator of mesodermal cell generation from EPL or other stem cells or maintaining or expanding mesodermal cells said composition further comprising one or more pharmaceutically acceptable carriers and/or diluents.
Specification